British American Tobacco stock gains almost 4% after strong results and optimism for reduced-risk products

Traders Union
All News
Financial News
British American Tobacco surges 3.79% today

Highlights

British American Tobacco advanced as strong earnings, regulatory easing, and cost-cutting measures bolstered confidence in its reduced-risk nicotine segment.
Management reaffirmed 2026 guidance at the lower revenue range, extended its buyback program, and maintained a 5.3% dividend yield.
Technicals indicate bullish positioning with price above key moving averages and expected consolidation between GBX4,596 and GBX4,818 over the next five days.

Cost-saving plans and buyback extension reinforce positive sentiment

British American Tobacco advanced following strong earnings and regulatory relief, which have strengthened optimism for its reduced-risk nicotine portfolio. The Fit2Win restructuring program targets £600 million in annual cost savings by 2028 through factory consolidation and a global workforce reduction of about 9,000 roles. The company has extended its share buyback program through July 29, 2026, and continues repurchasing shares ahead of half-year results set for July 30. Management reaffirmed full-year 2026 guidance at the lower end of its revenue range, reported ongoing growth in the U.S. business and new categories, and maintained a quarterly dividend yield of approximately 5.3%, with the next payout scheduled for August 2025.

Anton Kharitonov, expert at Traders Union, is cautious about the recent rally in British American Tobacco. He notes the stock is above all key moving averages, but technical signals remain mixed. Kharitonov points out that MACD and ADX highlight weak underlying momentum. He questions the sustainability of bullish sentiment, especially with reported overbought conditions and only modest revenue guidance reaffirmed. Fundamental drivers such as regulatory relief and cost savings are positive, but execution risks remain. "I see limited upside unless momentum improves or management delivers consistent earnings surprises," Kharitonov says.

Viktoras Karapetjanc, expert at Traders Union, highlights strong earnings and regulatory wins as drivers for sustained confidence in British American Tobacco. He believes the Fit2Win restructuring and extended buyback program set a solid base for further growth. The bullish technical structure remains intact above all main averages, confirming loyalty from investors. Karapetjanc expects continued expansion in reduced-risk products and resilient US demand to support upside. "The market offers multiple setups for upside as momentum builds on impressive fundamentals," he says.

Mixed momentum diverges as price holds above technical support

British American Tobacco is trading at GBX4,707, positioned above its 20-day, 50-day, and 200-day moving averages (GBX4,557, GBX4,593, and GBX4,329). This alignment signals strength across all timeframes, confirming a bullish medium- to long-term trend, with the near-term ceiling at GBX4,818 and support at today's high of GBX4,702. Momentum readings are mixed: MACD and ADX indicate weak or bearish momentum, while RSI, CCI, and AO suggest the stock lacks strong upward drive. Stochastic RSI points to a strong buy, highlighting oversold conditions, and BBP shows buyers are dominating intraday momentum while flagging an overbought environment. The stock opened 2.98% higher, rose 172 points or 3.79% for the day, and is trading near session highs with intraday volatility at 1.75%. The intraday tone signals notable strength toward highs, but momentum signals remain conflicted.

Earlier, analysts noted that British American Tobacco's bullish trend was tempered by mixed technical momentum and the potential for consolidation despite ongoing restructuring and share buybacks. The latest earnings-driven rally and regulatory support reinforce the positive long-term outlook, but traders should focus on whether the stock can decisively clear the GBX4,818 resistance, which would be the signal for a renewed breakout.

Source of Data: BATS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.